 <h1>Reminyl Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>galantamine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about galantamine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Reminyl.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to galantamine: oral capsule extended release, oral solution, oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, galantamine (the active ingredient contained in Reminyl) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking galantamine:</p><p>
<i>Less common</i>
</p><ul>
<li>Chest pain or discomfort</li>
<li>lightheadedness, dizziness, or fainting</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>shortness of breath</li>
<li>slow or irregular heartbeat</li>
<li>unusual tiredness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>decreased urination</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling of warmth</li>
<li>rapid breathing</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sunken eyes</li>
<li>sweating</li>
<li>thirst</li>
<li>troubled breathing</li>
<li>unusual tiredness or weakness</li>
<li>wrinkled skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>chills</li>
<li>cough</li>
<li>dark urine</li>
<li>fever</li>
<li>general tiredness and weakness</li>
<li>headache</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>light-colored stools</li>
<li>nausea and vomiting</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>rash, hives, or itching skin</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>troubled swallowing</li>
<li>upper right abdominal or stomach pain</li>
<li>yellow eyes and skin</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking galantamine:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Confusion</li>
<li>convulsions</li>
<li>irregular, fast or slow, or shallow breathing</li>
<li>muscle weakness</li>
<li>pale or blue lips, fingernails, or skin</li>
<li>severe nausea</li>
<li>stomach cramps</li>
<li>sweating</li>
<li>tearing of the eyes</li>
<li>twitches of the muscle visible under the skin</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of galantamine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Decreased appetite</li>
<li>weight loss</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>discouragement</li>
<li>feeling sad or empty</li>
<li>general feeling of discomfort or illness</li>
<li>heartburn</li>
<li>increased sweating</li>
<li>indigestion</li>
<li>irritability</li>
<li>lack of appetite</li>
<li>lack or loss of strength</li>
<li>loss of interest or pleasure</li>
<li>muscle spasms</li>
<li>stomach discomfort, upset, or pain</li>
<li>trouble concentrating</li>
<li>trouble sleeping</li>
<li>unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>change in taste</li>
<li>dry heaves</li>
<li>loss of taste</li>
<li>unusually deep sleep</li>
<li>unusually long duration of sleep</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>hearing loss</li>
<li>seeing, hearing, or feeling things that are not there</li>
</ul><p>
<!-- end oral capsule extended release, oral solution, oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to galantamine: oral capsule extended release, oral solution, oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Syncope, bradycardia</p>
<p><b>Frequency not reported</b>: First degree atrioventricular (AV) block, palpitations, sinus bradycardia, supraventricular extrasystoles, flushing, hypotension </p>
<p><b>Postmarketing reports</b>: Complete AV block, hypertension<sup>[Ref]</sup></p><p>Two randomized, placebo controlled trials revealed increased deaths in galantamine-treated patients with mild cognitive impairment.  A total of 13 deaths occurred among galantamine-treated patients (n=1026) and 1 patient on placebo (n=1022).  The deaths were due to various causes; about half of the galantamine deaths appeared to result from various vascular causes (myocardial infarction, stroke, and sudden death).<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Hyperhidrosis </p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, Acute generalized exanthematous pustulosis, Erythema multiforme</p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea, vomiting</p>
<p><b>Common</b> (1% to 10%): Diarrhea, abdominal pain, upper abdominal pain, dyspepsia, stomach discomfort, abdominal discomfort</p>
<p><b>Uncommon</b> (0.1% to 1%): Retching</p>
<p><b>Postmarketing reports</b>: Upper and lower GI bleeding, stomach discomfort, and abdominal discomfort.<sup>[Ref]</sup></p><p>The median duration of nausea in clinical trials was 5 to 7 days.  The most commonly occurring adverse reactions associated with discontinuation have include nausea (6.2%), vomiting (3.3%), decreased appetite (1.5%), and dizziness (1.3%).<sup>[Ref]</sup></p><h3>General</h3><p>The most common side effects associated with discontinuation were nausea, vomiting, decreased appetite, dizziness, diarrhea, headache, and decreased appetite.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, hematuria</p>
<p><b>Frequency not reported</b>: Increased libido<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatitis, increased hepatic enzymes</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity</p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, decreased weight, anorexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Dehydration</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms</p>
<p><b>Uncommon</b> (0.1% to 1%): Muscular weakness</p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, tremor, somnolence, lethargy</p>
<p><b>Frequency not reported</b>: Dysgeusia, hypersomnia, paresthesia</p>
<p><b>Postmarketing reports</b>: Seizures<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, malaise</p>
<p><b>Uncommon</b> (0.1% to 1%): Fall</p>
<p><b>Postmarketing reports</b>: Tinnitus</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Frequency not reported</b>: Apathy, paranoia (disagreeable or terrifying dreams), paranoid reaction, increased libido, delirium, suicidal ideation and suicide</p>
<p><b>Postmarketing reports</b>: Hallucination, visual hallucination, auditory hallucination<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Reminyl (galantamine)" Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_2">2. "Product Information. Razadyne (galantamine)." Johnson and Johnson Medical Inc, Arlington, TX. </p><p id="ref_3">3. Iraqi A,  Hughes TL "An unusual case of nightmares with galantamine." J Am Geriatr Soc 57 (2009): 565</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Reminyl (galantamine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: cholinesterase inhibitors</li>
<li>FDA Alerts (2)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Razadyne, Razadyne ER</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Alzheimer's Disease</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to galantamine: oral capsule extended release, oral solution, oral tablet</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Syncope, bradycardia</p><p><b>Frequency not reported</b>: First degree atrioventricular (AV) block, palpitations, sinus bradycardia, supraventricular extrasystoles, flushing, hypotension </p><p><b>Postmarketing reports</b>: Complete AV block, hypertension<sup>[Ref]</sup></p><p>Two randomized, placebo controlled trials revealed increased deaths in galantamine-treated patients with mild cognitive impairment.  A total of 13 deaths occurred among galantamine-treated patients (n=1026) and 1 patient on placebo (n=1022).  The deaths were due to various causes; about half of the galantamine deaths appeared to result from various vascular causes (myocardial infarction, stroke, and sudden death).<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Hyperhidrosis </p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, Acute generalized exanthematous pustulosis, Erythema multiforme</p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea, vomiting</p><p><b>Common</b> (1% to 10%): Diarrhea, abdominal pain, upper abdominal pain, dyspepsia, stomach discomfort, abdominal discomfort</p><p><b>Uncommon</b> (0.1% to 1%): Retching</p><p><b>Postmarketing reports</b>: Upper and lower GI bleeding, stomach discomfort, and abdominal discomfort.<sup>[Ref]</sup></p><p>The median duration of nausea in clinical trials was 5 to 7 days.  The most commonly occurring adverse reactions associated with discontinuation have include nausea (6.2%), vomiting (3.3%), decreased appetite (1.5%), and dizziness (1.3%).<sup>[Ref]</sup></p><h3>General</h3><p>The most common side effects associated with discontinuation were nausea, vomiting, decreased appetite, dizziness, diarrhea, headache, and decreased appetite.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, hematuria</p><p><b>Frequency not reported</b>: Increased libido<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Hepatitis, increased hepatic enzymes</p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Hypersensitivity</p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Decreased appetite, decreased weight, anorexia</p><p><b>Uncommon</b> (0.1% to 1%): Dehydration</p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Muscle spasms</p><p><b>Uncommon</b> (0.1% to 1%): Muscular weakness</p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness, tremor, somnolence, lethargy</p><p><b>Frequency not reported</b>: Dysgeusia, hypersomnia, paresthesia</p><p><b>Postmarketing reports</b>: Seizures<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, asthenia, malaise</p><p><b>Uncommon</b> (0.1% to 1%): Fall</p><p><b>Postmarketing reports</b>: Tinnitus</p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p><p><b>Frequency not reported</b>: Apathy, paranoia (disagreeable or terrifying dreams), paranoid reaction, increased libido, delirium, suicidal ideation and suicide</p><p><b>Postmarketing reports</b>: Hallucination, visual hallucination, auditory hallucination<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Rhinitis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Reminyl (galantamine)" Janssen Pharmaceuticals, Titusville, NJ. </p><p id="ref_2">2. "Product Information. Razadyne (galantamine)." Johnson and Johnson Medical Inc, Arlington, TX. </p><p id="ref_3">3. Iraqi A,  Hughes TL "An unusual case of nightmares with galantamine." J Am Geriatr Soc 57 (2009): 565</p><h2>More about Reminyl (galantamine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: cholinesterase inhibitors</li>
<li>FDA Alerts (2)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Alzheimer's Disease</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>